These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28118372)

  • 21. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
    Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
    BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience.
    Maurya AK; Singh AK; Kumar M; Umrao J; Kant S; Nag VL; Kushwaha RA; Dhole TN
    Indian J Med Microbiol; 2013; 31(1):40-6. PubMed ID: 23508428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug-resistant tuberculosis in Europe, 2010-2011.
    Günther G; van Leth F; Alexandru S; Altet N; Avsar K; Bang D; Barbuta R; Bothamley G; Ciobanu A; Crudu V; Davilovits M; Dedicoat M; Duarte R; Gualano G; Kunst H; de Lange W; Leimane V; Magis-Escurra C; McLaughlin AM; Muylle I; Polcová V; Pontali E; Popa C; Rumetshofer R; Skrahina A; Solodovnikova V; Spinu V; Tiberi S; Viiklepp P; Lange C;
    Emerg Infect Dis; 2015 Mar; 21(3):409-16. PubMed ID: 25693485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.
    Chen S; Huai P; Wang X; Zhong J; Wang X; Wang K; Wang L; Jiang S; Li J; Peng Y; Ma W
    Int J Infect Dis; 2013 Dec; 17(12):e1116-20. PubMed ID: 23916547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009-2013.
    Zhang L; Meng Q; Chen S; Zhang M; Chen B; Wu B; Yan G; Wang X; Jia Z
    Clin Microbiol Infect; 2018 Apr; 24(4):381-388. PubMed ID: 28712668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
    Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
    Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
    Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
    Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug resistance among persons with tuberculosis in California, 1994-2003.
    Granich RM; Oh P; Lewis B; Porco TC; Flood J
    JAMA; 2005 Jun; 293(22):2732-9. PubMed ID: 15941802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
    Judge D; Krause V
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil.
    da Silva Garrido M; Ramasawmy R; Perez-Porcuna TM; Zaranza E; Chrusciak Talhari A; Martinez-Espinosa FE; Bührer-Sékula S
    Int J Tuberc Lung Dis; 2014 May; 18(5):559-63. PubMed ID: 24903793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
    Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
    BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.